Latest MS drug approved by FDA hailed as a major breakthrough

NEW HAVEN, Conn. (WTNH)–Every year, hundreds lace up their sneakers for the Walk MS in Connecticut, raising thousands for local programs and services for families affected by multiple sclerosis, a chronic disease that attacks the central nervous system.

It also helps fund research–paving the way for the development of much needed drugs like this one.

“I wouldn’t want to use the word cure but it may be as close that we can get to a cure.”

Well known neurologist Dr. David Hafler with the Yale Multiple Sclerosis Center, led a secondary clinical trial on the recently FDA approved – Ocrevus.

He points to video, “Here we have the b-cells, which are interacting with the t-cells, which are attacking the nervous system.”

The drug attacks the b-cells in the brain and by doing so turns off the t-cells.

“If you don’t allow the t-cells to get activated then you stop the disease.”

It works best for patients recently diagnosed with M-S.

“If someone has new onset-MS, we believe this should be a first line drug, to see if it can stop the inflammation. It appears to be incredibly effective in terms of stopping the early, early disease.”

The intravenous treatment — was also approved for primary progressive M-S.

“It does appear to have a modest effect but not nearly as dramatic as in relapsing remitting disease.”

Still, Dr. Hafler says it’s a major breakthrough.

“What we don’t know and this will take decades to really figure out– is if you stop the very early inflammation, the relapsing remitting, do you prevent patients from going into the progressive phase? Time will tell but our guess is that it will.”

Walk MS starts this weekend and goes through May. There are nine sites across the state.

News 8’s Darren Kramer and Teresa Dufour will be in Cheshire this Sunday.

Registration is at nine am. The walk is at 10.

For more information on Walk MS, visit www.ctfightsMS.org.

Yale Multiple Sclerosis Center – 6 Devine Street, Suite 2B, North Haven, CT 06473
Call 203-287-6100 or log onto https://medicine.yale.edu/neurology/patients/neuro_immunology/?organizationId=109601

WTNH NEWS8 provides commenting to allow for constructive discussion on the stories we cover. In order to comment here, you acknowledge you have read and agreed to our Terms of Service. Commenters who violate these terms, including use of vulgar language or racial slurs, will be banned. Please be respectful of the opinions of others. If you see an inappropriate comment, please flag it for our moderators to review. Also, you can now block any inappropriate user by simple selecting the drop down menu on the right of any comment and selection "Block User" from there.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s